Related Experiment Video
Updated: Aug 5, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Effect of catecholamines on pulmonary circulation at elevated vascular tone
1Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912, USA.
Catecholamines affect canine pulmonary vasculature by altering resistance and compliance via alpha and beta receptors. These effects diminish when vascular tone is elevated, impacting lung fluid balance.
Area of Science:
- Pulmonary Circulation Physiology
- Adrenergic Receptor Pharmacology
Background:
- Catecholamines like norepinephrine and epinephrine influence vascular tone.
- Pulmonary vascular resistance and compliance are critical determinants of lung function.
Purpose of the Study:
- To investigate the impact of catecholamine stimulation on pulmonary vascular resistance and compliance.
- To examine how elevated vascular tone modifies catecholamine effects in the canine pulmonary circulation.
Main Methods:
- Isolated dog lung blood perfusion at constant flow.
- Utilized arterial, venous, and double-occlusion techniques to measure segmental resistances and compliances.
- Evaluated responses under control and elevated vascular tone (induced by U-46619).
Main Results:
- Under normal tone, catecholamines increased pulmonary vascular resistance and decreased compliance via alpha and beta receptor stimulation.
- Epinephrine demonstrated a stronger effect on beta 2-receptors than norepinephrine.
- With elevated vascular tone, catecholamine effects on resistance were abolished, and compliance was unaffected.
Conclusions:
- Adrenergic receptor systems modulating pulmonary vascular tone are altered by elevated vascular tone.
- These alterations may influence pulmonary capillary pressure and lung fluid balance.
Related Concept Videos
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Pathophysiology of Cardiac Performance
Heart Failure Drugs: β-Blockers

